Abstract:OBJECTIVETo understand the influence of angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and beta3-adrenergic receptor (beta3-AR) gene Trp64Arg polymorphism on fetal growth and neonatal insulin sensitivity.METHODSTotally 296 newborn infants were selected into our study and divided into 2 groups according to gestational age and birth weight: adequate-for-gestational-age (AGA) group (222 cases) and small-for-gestational-age (SGA) group (74 case). Serum glucose and insulin were examined in the morning of the 3rd day before milk. Insulin sensitivity was evaluated by homeostasis model assessment (HOMA) equation. beta3-AR gene Trp64Arg polymorphism and ACE gene I/D polymorphism (202 cases) were analysed using polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP) technique. Gestational age, birth weight, birth weight percentage, serum glucose, insulin and HOMA-IR were compared among different genotype groups. Statistical analysis was performed with the SPSS 10.0 software.RESULTSNo significant difference was found between the serum glucose level of SGA group (4.03 +/- 1.05 mmol/L) and AGA group (4.05 +/- 1.14 mmol/L), P = 0.008. The serum insulin level (converted into Ln) of SGA group (2.262 +/- 0.746) was significantly higher than that of AGA group (1.757 +/- 0.805), P < 0.001. The HOMA-IR (also converted into Ln) level of SGA group (0.217 +/- 0.367) was also significantly higher than that of AGA group (0.001 +/- 0.378), P < 0.001. In the SGA group beta3-AR gene Arg64 allele carriers had higher serum insulin and HOMA-IR level (both changed to Ln, 2.654 +/- 0.701, 0.371 +/- 0.338) compared with noncarriers (2.074 +/- 0.698, 0.143 +/- 0.360), P < 0.05. The ACE gene DD genotype carriers had higher serum insulin and HOMA-IR level (both were converted into Ln, 2.19 +/- 0.91, 0.51 +/- 1.01) compared with II (1.77 +/- 0.85, 0.02 +/- 0.93) and ID genotype group (1.77 +/- 0.83, 0.05 +/- 0.91), P < 0.05. The ACE gene DD carriers had lower birth weight percentage compared with II and ID genotype group, P < 0.05. When both genes' polymorphisms were taken into account, the newborns who had both DD genotype and Arg64 allele had obviously higher serum insulin level (Ln, 2.560 +/- 1.160) than the neonates who had only one of the polymorphisms mentioned above (1.970 +/- 0.821, 1.992 +/- 0.706) and the neonates who had neither of the two polymorphisms (1.683 +/- 0.832), P < 0.05. The newborns who had both DD genotype and Arg64 allele also had significantly higher HOMA-IR level (Ln, 1.042 +/- 1.315) than the neonates who had only one of the polymorphisms mentioned above (0.247 +/- 0.710, 0.230 +/- 0.890) and the neonates who had neither of the two polymorphisms (-0.053 +/- 0.924), P < 0.05.CONCLUSIONNewborns SGA had impaired insulin sensitivity. beta3-AR gene Trp64Arg polymorphism and ACE gene I/D polymorphism are important factors that may connect IUGR with insulin resistance syndrome in adulthood.

Relationship between Serum Enzyme Activity and Angiotensin-Converting Enzyme Gene Insertion or Deletion Polymorphism of Preterm Infants in Neonatology Intensive Care Unit

[Relationship of the Disease Severity with ACE Gene Polymorphism and Serum ACE Activity in Preterm Infants].

Relationship Between Angiotensin Converting Enzyme Gene Insertion/deletion Polymorphism and the Severe Morbidity of Neonates

[Relationship Between ACE Gene Insertion or Deletion Polymorphism and Left Ventricular Mass in Newborns Admitted to the Neonatal Intensive Care Unit].

Association of the Genetic Polymorphism of Angiotensin-Converting Enzyme and Idiopathic Dilated Cardiomyopathy

Relationship between angiotensin-converting enzyme gene insertion or deletion polymorphism and insulin sensitivity in healthy newborns

Relationship between angiotensin-converting enzyme gene insertion or deletion polymorphism and insulin sensitivity in healthy newborns.

[Influence of Angiotensin Converting Enzyme Gene Insertion/deletion Polymorphism and Beta3-Adrenergic Receptor Gene Trp64Arg Polymorphism on Fetal Growth and Neonatal Insulin Sensitivity].

ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM IN UNTREATED ESSENTIAL HYPERTENSION AND RESPONSE TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS

Association Study of Angiotensin Converting Enzyme Polymorphism with Myocardial Infarction in Chinese

The association between polymorphism in the promoter region of insulin-like growth factorⅠ gene and the serum level of IGF-Ⅰ in neonates

Influence of ACE gene I/D polymorphism and insulin receptor substrate-1 gene Giy972Arg polymorphism on birthweight

Polymorphism of angiotensin converting enzyme in Han populations and its relevance to the severity of coronary atherosclerosis]

Characteristics of polymorphism in promoter region of insulin-like growth factor-1 gene in 561 neonates

Association Between the Angiotensin‐converting Enzyme Gene Insertion/deletion Polymorphism and First‐episode Patients with Schizophrenia in a Chinese Han Population

The Polymorphism of Angiotensin I-converting Enzyme Gene in Tumor Tissue of Esophageal Carcinoma Patients

Insertion/deletion Polymorphism of the Angiotensin I—converting Enzyme Gene in Patients with Hypertension, Non—insulin-Dependent Diabetes Mellitus, and Coronary Heart Disease in Taiwan

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Association Between Angiotensin Converting Enzyme Gene, Chymase Gene and Regression of Left Ventricular Hypertrophy in Patients Treated with Angiotensin Converting Enzyme Inhibitors

Association Between Angiotensin-Converting Enzyme Gene Polymorphism and Diabetic Retinopathy in the Chinese Population

Study of serum NT-proBNP levels and warning mechanism in common diseases of neonates